Thomas McEachin
Director · Pediatrix Medical Group, Inc.
- 2025
- Aug 14, 2026
- 6
Summary
Latest filing:
Thomas McEachin is Director of Pediatrix Medical Group, Inc. (MD). 6 SEC Form 4 filings on record going back to 2025, most recently on 14 August 2026.
Recent transactions
10The latest 10 SEC Form 4 transactions reported by Thomas McEachin.
Trading pattern
InsiderAlpha's records for Thomas McEachin go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thomas McEachin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shirley A. Weis - $856K in MD purchases and sales in the last 12 months
- Mark S. Ordan - $515K in MD purchases and sales in the last 12 months
- Michael A. Rucker - $241K in MD purchases and sales in the last 12 months
- Laura A. Linynsky - $217K in MD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thomas McEachin?
Thomas McEachin is a corporate insider, tracked as Director of Pediatrix Medical Group, Inc. (MD). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Thomas McEachin submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.